Researchers in Australia have led a first-in-human trial for a breakthrough gene-editing therapy that halves bad cholesterol ...

A statin isn’t the only answer anymore to lowering cholesterol. The lipid-reducing medicines, among the most widely prescribed drugs in the U.S., have been a mainstay of heart-disease prevention and ...

The convergence of AI, quantum computing, and biosciences is propelling the global healthcare industry into a new era - now projected to surpass US$1.7 trillion in AI-driven biotech spending by 2025, ...

Researchers have developed a synthetic regeneration system for genetically editing crops, avoiding the challenging step of ...

Kala Bio has secured a $375,000 convertible loan from an investor to negotiate more funding and avoid foreclosure by Oxford ...

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions ('Dyadic'), a global biotechnology ...

The company scans entire proteins with CRISPR to find functional vulnerabilities, then hunts for molecules that exploit them ...

Access to ERS Genomics’ foundational CRISPR/Cas9 patent portfolio expands our genetic engineering toolkit and strengthens our ability to speed up and optimize strain development across Dyadic’s ...

Phase 1 data showed CRISPR’s one-time treatment, CTX310, produced sharp, dose-dependent reductions in triglycerides and LDL cholesterol with a strong safety profile. ・The company plans to advance the ...

Life sciences revolve around many living forms such as humans, plants, animals, and microorganisms. The discoveries made ...

Yi Li, professor of horticultural plant breeding biotechnology in the College of Agriculture, Health and Natural Resources ...

A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...